Successful Treatment of Steroid-Resistant Minimal Change Disease with Mycophenolate Mofetil

Publisher： Karger

E-ISSN： 1421-9670|22|5-6|569-572

ISSN： 0250-8095

Source： American Journal of Nephrology, Vol.22, Iss.5-6, 2002-10, pp. : 569-572

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Novel Trial for the Treatment of Steroid Dependency in Minimal Change Disease: Combined Therapy of Camostat Mesilate and Glycyrrhizin

By  

Nephron, Vol. 90, Iss. 3, 2002-02 ,pp. : 357-360

Karger

Access to resources Recommend Favorite

Treatment of Lupus Nephritis by Mycophenolate Mofetil

By  

Kidney and Blood Pressure Research, Vol. 33, Iss. 4, 2010-07 ,pp. : 297-303

Karger

Access to resources Recommend Favorite

Steroid-Resistant Nephrotic Syndrome Associated with Kimura’s Disease

By  

American Journal of Nephrology, Vol. 22, Iss. 4, 2002-08 ,pp. : 381-384

Karger

Access to resources Recommend Favorite

Urinary Soluble HLA Class I Antigen in Patients with Minimal Change Disease: A Predictor of Steroid Response

By  

Nephron, Vol. 79, Iss. 1, 1998-04 ,pp. : 44-49

Karger

Access to resources Recommend Favorite

Safety of the Allopurinol-Mycophenolate Mofetil Combination in the Treatment of Hyperuricemia of Kidney Transplant Recipients

By  

Nephron, Vol. 91, Iss. 1, 2002-05 ,pp. : 173-174

Karger

Access to resources Recommend Favorite